 | Up a level |
McClung, M R; Lippuner, Kurt; Brandi, M L; Zanchetta, J R; Bone, H G; Chapurlat, R; Hans, D; Wang, A; Zapalowski, C; Libanati, C (2017). Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis. Osteoporosis international, 28(10), pp. 2967-2973. Springer 10.1007/s00198-017-4140-y
Ferrari, S; Adachi, J D; Lippuner, Kurt; Zapalowski, C; Miller, P D; Reginster, J-Y; Törring, O; Kendler, D L; Daizadeh, N S; Wang, A; O'Malley, C D; Wagman, R B; Libanati, C; Lewiecki, E M (2015). Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years. Osteoporosis international, 26(12), pp. 2763-2771. Springer 10.1007/s00198-015-3179-x
Papapoulos, S; Lippuner, Kurt; Roux, C; Lin, C J F; Kendler, D L; Lewiecki, E M; Brandi, M L; Czerwiński, E; Franek, E; Lakatos, P; Mautalen, C; Minisola, S; Reginster, J Y; Jensen, S; Daizadeh, N S; Wang, A; Gavin, M; Libanati, C; Wagman, R B and Bone, H G (2015). The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study. Osteoporosis international, 26(12), pp. 2773-2783. Springer 10.1007/s00198-015-3234-7
Cummings, SR; San, Martin J; McClung, MR; Siris, ES; Eastell, R; Reid, IR; Delmas, P; Zoog, HB; Austin, M; Wang, A; Kutilek, S; Adami, S; Zanchetta, J; Libanati, C; Siddhanti, S; Christiansen, C; FREEDOM, Trial (2009). Denosumab for prevention of fractures in postmenopausal women with osteoporosis. New England journal of medicine NEJM, 361(8), pp. 756-765. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa0809493
